한글목차

세계의 디지털 PCR 시장은 2024년 8억 1,456만 달러로 평가되었으며, 예측 기간 동안 CAGR 9.23%를 나타낼 전망이며, 2030년까지 13억 7,262만 달러에 이를 것으로 예측됩니다.

세계의 디지털 PCR(dPCR) 시장은 분자진단의 진보와 정확한 핵산 정량에 대한 요구가 높아짐에 따라 대폭적인 성장을 이루고 있습니다. 표준 곡선을 필요로하지 않고 표적 DNA 또는 RNA의 절대 정량이 가능하기 때문에 종양학, 감염증 검출, 유전자 연구 등의 용도에 특히 유용합니다. 특히 디지털 PCR의 저수준 돌연변이와 희귀한 유전자 돌연변이를 검출하는 능력은 맞춤형 의료 및 액체 바이오시 응용 분야에서 필수적인 도구가 되고 있습니다.

시장 성장 촉진요인

감염과 만성 질환 증가

주요 시장 과제

디지털 PCR 장비 및 소모품의 고비용

주요 시장 동향

기술과 자동화의 진보

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계 디지털 PCR 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 유형별(드롭렛 디지털 PCR, 칩 베이스 디지털 PCR, 기타)
  • 구성 요소별(시스템, 키트 및 분석, 시약 및 소모품)
  • 용도별(종양학, 감염증, 희귀질환, 생식 유전학, 기타)
  • 최종 사용자별(학술연구기관, 바이오테크놀러지 및 제약기업, 병원 및 클리닉, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 유형별
  • 컴포넌트별
  • 용도별
  • 최종 사용자별
  • 지역별

제6장 북미의 디지털 PCR 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미: 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 디지털 PCR 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽: 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 디지털 PCR 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양: 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 디지털 PCR 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카 디지털 PCR 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카: 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제13장 경쟁 구도

• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN NV
• Thermo Fisher Scientific Inc.
• Genetron Holdings Limited
• Naveris, Inc.
• SAGA Diagnostics
• Precigenome LLC

제14장 전략적 제안

제15장 기업 소개와 면책사항

영문목차

Global Digital PCR Market was valued at USD 814.56 million in 2024 and is expected to reach USD 1372.62 million by 2030 with a CAGR of 9.23% during the forecast period. The global digital PCR (dPCR) market is witnessing substantial growth, driven by advancements in molecular diagnostics and the growing need for precise nucleic acid quantification. Digital PCR technology has emerged as a powerful tool for detecting and quantifying genetic material with high sensitivity and specificity, offering advantages over traditional PCR techniques. It allows for absolute quantification of target DNA or RNA without the need for standard curves, making it especially useful in applications such as oncology, infectious disease detection, and genetic research. The rising prevalence of cancer and infectious diseases, along with increasing demand for accurate diagnostic tools, is contributing to the widespread adoption of digital PCR across clinical and research settings. Technological innovations, such as droplet-based and chip-based dPCR platforms, have improved throughput, multiplexing capability, and ease of use, further driving market penetration. In particular, the ability of digital PCR to detect low-level mutations and rare genetic variants makes it an essential tool in personalized medicine and liquid biopsy applications. In addition to healthcare, the technology is also being adopted in fields like food safety, environmental monitoring, and forensic science.

Key Market Drivers

Rising Prevalence of Infectious and Chronic Diseases

The rising prevalence of infectious and chronic diseases is a significant driver of growth in the global digital PCR (dPCR) market. Infectious diseases such as COVID-19, influenza, HIV, tuberculosis, and hepatitis continue to challenge healthcare systems worldwide, highlighting the urgent need for highly sensitive, specific, and rapid diagnostic tools. For instance, according to WHO 2024, noncommunicable diseases (NCDs) caused 43 million deaths in 2021, representing 75% of global non-pandemic deaths. Of these, 18 million were premature deaths under age 70, with 82% occurring in low- and middle-income countries. Cardiovascular diseases led NCD fatalities at 19 million, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes-related deaths exceeding 2 million.

Digital PCR has emerged as a valuable technology in this context, capable of detecting minute quantities of viral or bacterial genetic material with remarkable accuracy. Its ability to quantify low-abundance targets makes it ideal for early detection, monitoring viral load, and tracking disease progression, all of which are critical for timely treatment and containment of infectious outbreaks. Beyond infectious diseases, the global burden of chronic conditions such as cancer, cardiovascular diseases, and genetic disorders is also rising steadily. In oncology, for example, dPCR plays a crucial role in the detection of rare mutations, analysis of circulating tumor DNA (ctDNA), and monitoring of minimal residual disease, supporting the move toward personalized medicine and targeted therapies. As these diseases often require long-term monitoring and precision in diagnosis, the demand for robust molecular diagnostic tools like dPCR continues to grow. The increasing incidence of co-morbidities and aging populations globally is driving the need for diagnostic technologies that offer both accuracy and efficiency. Digital PCR provides an edge by enabling absolute quantification without the need for standard curves, making it highly reliable for clinical decision-making. In regions with limited healthcare infrastructure, dPCR's precision can be particularly valuable in overcoming diagnostic challenges.

Key Market Challenges

High cost of digital PCR instruments and consumables

The high cost of digital PCR (dPCR) instruments and consumables is a significant challenge impacting the growth and accessibility of the global digital PCR market. Digital PCR technology involves sophisticated instrumentation that requires advanced engineering, precise microfluidics, and sensitive detection systems, all of which contribute to the elevated price of these platforms compared to traditional PCR methods. For many laboratories, especially smaller research facilities and those in developing regions, the initial capital investment for purchasing dPCR machines can be prohibitively expensive. This high upfront cost limits the widespread adoption of the technology, despite its clear advantages in sensitivity and accuracy. In addition to the instrument cost, consumables such as reagents, chips, or droplets used in digital PCR assays tend to be more expensive than those used in conventional PCR. These consumables are often proprietary and must be purchased from specific manufacturers, which further drives up operational expenses. The recurring cost of consumables can strain the budgets of clinical laboratories and research institutions, particularly when large sample volumes need to be analyzed regularly. This cost barrier also affects the integration of digital PCR into routine clinical diagnostics, as healthcare providers may be reluctant to adopt expensive technologies without clear reimbursement policies or cost-benefit evidence. In resource-limited settings, the affordability of the technology remains a major concern, slowing the adoption of dPCR where it could significantly improve diagnostic accuracy. Addressing these cost challenges through technological innovation aimed at reducing manufacturing expenses, increasing automation, and promoting competitive pricing is crucial for expanding the digital PCR market. Additionally, developing cost-effective consumable solutions and fostering partnerships to improve affordability will help increase accessibility and adoption globally.

Key Market Trends

Advancement in Technology and Automation

Advancements in technology and automation are key drivers transforming the global digital PCR (dPCR) market. Recent innovations have focused on improving the accuracy, speed, and user-friendliness of dPCR platforms, making them more accessible and efficient for a broader range of applications. Automated systems now integrate sample preparation, partitioning, amplification, and data analysis into streamlined workflows, significantly reducing manual intervention and the potential for human error. This automation enhances reproducibility and throughput, addressing the demand for faster turnaround times in clinical and research laboratories. Technological progress has also led to the development of more sensitive and versatile dPCR platforms, including droplet-based and chip-based systems capable of multiplexing-simultaneously detecting multiple targets within a single sample. These improvements enable more comprehensive genetic analysis and reduce costs by maximizing data output per run.

User-friendly software with advanced algorithms now supports more straightforward data interpretation, enabling laboratories with limited bioinformatics expertise to adopt digital PCR more easily. Additionally, miniaturization and portable dPCR devices are emerging, facilitating point-of-care testing and on-site analysis, which expands the technology's applicability beyond centralized labs. Advancements in technology and automation are not only improving the performance and reliability of digital PCR but are also lowering operational barriers, accelerating adoption, and expanding market reach across healthcare and non-healthcare sectors.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Genetron Holdings Limited
• Naveris, Inc.
• SAGA Diagnostics
• Precigenome LLC

Report Scope:

In this report, the Global Digital PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital PCR Market, By Type:

• Droplet Digital PCR
• Chip Based Digital PCR
• Others

Digital PCR Market, By Component:

• Systems
• Kits and Assays
• Reagents and Consumables

Digital PCR Market, By Application:

• Oncology
• Infectious Diseases
• Rare Diseases
• Reproductive Genetics
• Others

Digital PCR Market, By End User:

• Academic and Research Institutions
• Biotechnology & Pharmaceutical Companies
• Hospitals and Clinics
• Others

Digital PCR Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital PCR Market.

Available Customizations:

Global Digital PCR Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital PCR Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Droplet Digital PCR, Chip Based Digital PCR, Others)
  • 5.2.2. By Component (Systems, Kits and Assays, Reagents and Consumables)
  • 5.2.3. By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)
  • 5.2.4. By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Component
  • 5.3.3. By Application
  • 5.3.4. By End User
  • 5.3.5. By Region

6. North America Digital PCR Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Component
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital PCR Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Digital PCR Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Digital PCR Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Digital PCR Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Component
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Digital PCR Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Digital PCR Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Digital PCR Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Digital PCR Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Digital PCR Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Digital PCR Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Component
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Digital PCR Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Digital PCR Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Digital PCR Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Digital PCR Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Digital PCR Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Digital PCR Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Component
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital PCR Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Digital PCR Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Digital PCR Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Digital PCR Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Component
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital PCR Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Digital PCR Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Digital PCR Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Bio-Rad Laboratories, Inc.
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Recent Developments
  • 13.1.6. SWOT Analysis
• 13.2. Fluidigm Corporation
• 13.3. F. Hoffmann-La Roche AG
• 13.4. Merck KGaA
• 13.5. QIAGEN N.V.
• 13.6. Thermo Fisher Scientific Inc.
• 13.7. Genetron Holdings Limited
• 13.8. Naveris, Inc.
• 13.9. SAGA Diagnostics
• 13.10. Precigenome LLC

14. Strategic Recommendations

15. About Us & Disclaimer